All Posts

Each year on February 15, International Childhood Cancer Day (ICCD) brings the world together to shine a light on the realities faced by children diagnosed with cancer—and the families who walk beside them. Pediatric brain tumors remain among the most complex and underfunded childhood cancers, yet research is where real change begins. Globally, there is a bold goal to eliminate pain and suffering for children fighting cancer and to achieve at least 60% survival for all chi

On February 3, 2026 the Mikaela Naylon Give Kids A Chance Act was passed into law! This is an important step forward in the fight against pediatric cancer and only happened because of the heroic advocacy of patients and families. This bill will provide much needed resources for the pediatric cancer community and help to develop new treatments. With new breakthroughs in medicine and technology happening every day it is more important than ever that we ensure that we are wor

Last week the House of Representatives unanimously passed the Mikaela Naylon Give Kids a Chance Act. This legislation will give the FDA authority to direct pediatric cancer trials for combination drugs, reauthorize the Rare Pediatric Priority Review Voucher, and provide more funds for NIH pediatric drug studies. This legislation is an important step forward in the fight to close gaps in pediatric cancer research and develop more effective, less toxic medicine. We applaud th

In this short State of the Science spotlight, Dr. Keren Sturtz , Executive Senior Director at Pfizer Oncology Early Clinical Development, shares why breakthroughs in pediatric brain cancer depend on one thing above all: everyone working together. Dr. Sturtz explains why rare pediatric brain tumors require creative thinkers, strong research infrastructure, and the combined efforts of academic centers, biotech innovators, big pharma, government funding—and philanthropy. She hi